메뉴 건너뛰기




Volumn 361, Issue 1, 2007, Pages 97-102

Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogue

Author keywords

Aminododecanoic; Conotoxin MII; Biodistribution; Lipoamino acid; Oral absorption

Indexed keywords

2 AMINO DEXTRO,LEVO DODECANOIC ACID; ALPHA CONOTOXIN MII; CHOLINERGIC RECEPTOR; LAURIC ACID; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

EID: 34547106305     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.138     Document Type: Article
Times cited : (26)

References (32)
  • 3
    • 9144272640 scopus 로고    scopus 로고
    • Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain
    • Miljanich G.P. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11 (2004)
    • (2004) Curr. Med. Chem. , vol.11
    • Miljanich, G.P.1
  • 4
    • 3042631514 scopus 로고    scopus 로고
    • Drugs from the sea: Conopeptides as potential therapeutics
    • Livett B.G., Gayler K.R., and Khalil Z. Drugs from the sea: Conopeptides as potential therapeutics. Curr. Med. Chem. 11 (2004) 1715-1723
    • (2004) Curr. Med. Chem. , vol.11 , pp. 1715-1723
    • Livett, B.G.1    Gayler, K.R.2    Khalil, Z.3
  • 5
    • 0025160022 scopus 로고
    • Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites
    • Ward J.M., Crockcroft V.B., Lunt G.G., Smillie F.S., and Wonnacott S. Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 270 (1990) 45-48
    • (1990) FEBS Lett. , vol.270 , pp. 45-48
    • Ward, J.M.1    Crockcroft, V.B.2    Lunt, G.G.3    Smillie, F.S.4    Wonnacott, S.5
  • 6
    • 0027518923 scopus 로고
    • Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium
    • Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13 (1993) 596-604
    • (1993) J. Neurosci. , vol.13 , pp. 596-604
    • Seguela, P.1    Wadiche, J.2    Dineley-Miller, K.3    Dani, J.A.4    Patrick, J.W.5
  • 7
    • 0025472462 scopus 로고
    • Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations
    • Luetje C.W., Wanda K., Rogers S., Abramson S.N., Tsuji K., Heinemann S., and Patrick J.W. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55 (1990) 632-640
    • (1990) J. Neurochem. , vol.55 , pp. 632-640
    • Luetje, C.W.1    Wanda, K.2    Rogers, S.3    Abramson, S.N.4    Tsuji, K.5    Heinemann, S.6    Patrick, J.W.7
  • 8
    • 0032881372 scopus 로고    scopus 로고
    • Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes
    • McIntosh J.M., Santos A.D., and Olivera B.M. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Ann. Rev. Biochem. 68 (1999) 59-88
    • (1999) Ann. Rev. Biochem. , vol.68 , pp. 59-88
    • McIntosh, J.M.1    Santos, A.D.2    Olivera, B.M.3
  • 9
    • 18744413004 scopus 로고    scopus 로고
    • a-Conotoxins as selective probes for nicotinic acetylchholine receptor subclasses
    • Janes R.W. a-Conotoxins as selective probes for nicotinic acetylchholine receptor subclasses. Curr. Opin. .Pharmacol. 5 (2005) 280-292
    • (2005) Curr. Opin. .Pharmacol. , vol.5 , pp. 280-292
    • Janes, R.W.1
  • 10
    • 33750957742 scopus 로고    scopus 로고
    • Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor
    • Livett B.G., Sandall D.W., Keays D., Down J., Gayler K.R., Satkunanathan N., and Khalil Z. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 48 (2006) 810-829
    • (2006) Toxicon , vol.48 , pp. 810-829
    • Livett, B.G.1    Sandall, D.W.2    Keays, D.3    Down, J.4    Gayler, K.R.5    Satkunanathan, N.6    Khalil, Z.7
  • 12
    • 0344406263 scopus 로고    scopus 로고
    • Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII
    • Blanchfield J., Dutton J., Hogg R., Gallagher O., Craik D., Jones A., Adams D., Lewis R., Alewood P., and Toth I. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J. Med. Chem. 46 (2003) 1266-1272
    • (2003) J. Med. Chem. , vol.46 , pp. 1266-1272
    • Blanchfield, J.1    Dutton, J.2    Hogg, R.3    Gallagher, O.4    Craik, D.5    Jones, A.6    Adams, D.7    Lewis, R.8    Alewood, P.9    Toth, I.10
  • 14
    • 0031469571 scopus 로고    scopus 로고
    • Three-dimensional solution structure of α-conotoxin MII, an α3β2 neuronal nicotinic acetylcholine receptor-targeted ligand
    • Shon K.-J., Koerber S.C., Rivier J.E., Olivera B.M., and McIntosh J.M. Three-dimensional solution structure of α-conotoxin MII, an α3β2 neuronal nicotinic acetylcholine receptor-targeted ligand. Biochem. 36 (1997) 15693-15700
    • (1997) Biochem. , vol.36 , pp. 15693-15700
    • Shon, K.-J.1    Koerber, S.C.2    Rivier, J.E.3    Olivera, B.M.4    McIntosh, J.M.5
  • 15
    • 0032506167 scopus 로고    scopus 로고
    • Three-dimensional solution structure of α-conotoxin MII by NMR spectroscopy: Effects of solution environment on helicity
    • Hill J.M., Oomen C.J., Miranda L.P., Bingham J.-P., Alewood P.F., and Craik D.J. Three-dimensional solution structure of α-conotoxin MII by NMR spectroscopy: Effects of solution environment on helicity. Biochem. 37 (1998) 15621-15630
    • (1998) Biochem. , vol.37 , pp. 15621-15630
    • Hill, J.M.1    Oomen, C.J.2    Miranda, L.P.3    Bingham, J.-P.4    Alewood, P.F.5    Craik, D.J.6
  • 16
    • 4444244953 scopus 로고    scopus 로고
    • Lipid, sugar and liposaccharide based delivery systems 2
    • Blanchfield J.T., and Toth I. Lipid, sugar and liposaccharide based delivery systems 2. Curr. Med. Chem. 11 (2004) 2375-2382
    • (2004) Curr. Med. Chem. , vol.11 , pp. 2375-2382
    • Blanchfield, J.T.1    Toth, I.2
  • 17
    • 0019480198 scopus 로고
    • Prodrugs as drug delivery systems
    • Bundgaard H., and Hansen B.B. Prodrugs as drug delivery systems. Pharmacy Int. (1981) 136-140
    • (1981) Pharmacy Int. , pp. 136-140
    • Bundgaard, H.1    Hansen, B.B.2
  • 18
    • 33846230530 scopus 로고    scopus 로고
    • Plasma protein binding affinity and its relationship to molecualr structure: An in-silico analysis
    • Gleeson P.M. Plasma protein binding affinity and its relationship to molecualr structure: An in-silico analysis. J. Med. Chem. 50 (2007) 101-112
    • (2007) J. Med. Chem. , vol.50 , pp. 101-112
    • Gleeson, P.M.1
  • 19
    • 34547104709 scopus 로고    scopus 로고
    • The correlation of serum protein association and cellular uptake with lipophilicity and polarity of the backbone substituent of the technitium-99m-amine-oxime chelates
    • Li L., Xu Y., and Su Z. The correlation of serum protein association and cellular uptake with lipophilicity and polarity of the backbone substituent of the technitium-99m-amine-oxime chelates. J. Label. Comp. Radiopharm. 50 (2007) 91-95
    • (2007) J. Label. Comp. Radiopharm. , vol.50 , pp. 91-95
    • Li, L.1    Xu, Y.2    Su, Z.3
  • 20
    • 33644788804 scopus 로고    scopus 로고
    • CNS drug delivery: opioid peptides and the blood-brain barrier
    • Witt K.A., and Davis T.P. CNS drug delivery: opioid peptides and the blood-brain barrier. AAPS Journal 8 (2006) E76-E88
    • (2006) AAPS Journal , vol.8
    • Witt, K.A.1    Davis, T.P.2
  • 21
    • 0034013024 scopus 로고    scopus 로고
    • Bioavailablity of Ziconotide in brain: influx from blood, stability and diffusion
    • Newcomb R., Abbruscata T.J., Singh T., Nadaski L., Davis T.P., and Miljanich G. Bioavailablity of Ziconotide in brain: influx from blood, stability and diffusion. Peptides 21 (2000) 491-501
    • (2000) Peptides , vol.21 , pp. 491-501
    • Newcomb, R.1    Abbruscata, T.J.2    Singh, T.3    Nadaski, L.4    Davis, T.P.5    Miljanich, G.6
  • 22
    • 22244488749 scopus 로고    scopus 로고
    • Oral delivery of peptide drugs
    • Hamman J.H., Enslin G.M., and Kotze A.F. Oral delivery of peptide drugs. Biodrugs 19 (2005) 165-177
    • (2005) Biodrugs , vol.19 , pp. 165-177
    • Hamman, J.H.1    Enslin, G.M.2    Kotze, A.F.3
  • 24
    • 0028009171 scopus 로고
    • Effect of a new oral somatostatin analog (SDZCO611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects
    • Nelson-Piercy C., Hammond P.J., Gwilliam M.E., Khandan-Nia N., Myers M.J., Ghatei M.A., and Bloom S.R. Effect of a new oral somatostatin analog (SDZCO611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J. Clin. Endocrin. Metab. 78 (1994) 329-336
    • (1994) J. Clin. Endocrin. Metab. , vol.78 , pp. 329-336
    • Nelson-Piercy, C.1    Hammond, P.J.2    Gwilliam, M.E.3    Khandan-Nia, N.4    Myers, M.J.5    Ghatei, M.A.6    Bloom, S.R.7
  • 25
    • 0347316399 scopus 로고    scopus 로고
    • Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a Phase I/II clinical trial
    • Clement S., Dandona P., Still G.J., and Kosutic G. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a Phase I/II clinical trial. Metabolism 53 (2004) 54-58
    • (2004) Metabolism , vol.53 , pp. 54-58
    • Clement, S.1    Dandona, P.2    Still, G.J.3    Kosutic, G.4
  • 26
    • 0036105205 scopus 로고    scopus 로고
    • Development of oral insulin: progress and current status
    • Still G.J. Development of oral insulin: progress and current status. Diabetes Metab. Res. Rev. 18 (2002) S29-S37
    • (2002) Diabetes Metab. Res. Rev. , vol.18
    • Still, G.J.1
  • 27
    • 0030596514 scopus 로고    scopus 로고
    • Oral absorption studies of lipidic conjugates of thyrotropin releasing hormone (TRH) and luteinizing hormone-releasing hormone (LHRH)
    • Flinn N., Coppard S., and Toth I. Oral absorption studies of lipidic conjugates of thyrotropin releasing hormone (TRH) and luteinizing hormone-releasing hormone (LHRH). Inter. J. Pharm. (1996) 33-39
    • (1996) Inter. J. Pharm. , pp. 33-39
    • Flinn, N.1    Coppard, S.2    Toth, I.3
  • 29
    • 0037467203 scopus 로고    scopus 로고
    • Reversible lipidization for the oral delivery of salmon calcitonin
    • Wang J., Chow D., Heiati H., and Shen W.-C. Reversible lipidization for the oral delivery of salmon calcitonin. J. Controll. Rel. 88 (2003) 369-380
    • (2003) J. Controll. Rel. , vol.88 , pp. 369-380
    • Wang, J.1    Chow, D.2    Heiati, H.3    Shen, W.-C.4
  • 30
    • 0032709221 scopus 로고    scopus 로고
    • Preparation, Purification and Characterization of a reversibaly lipidized desmopressin with potentiated anti-diuretic activity
    • Wang J., Shen D., and Shen W.-C. Preparation, Purification and Characterization of a reversibaly lipidized desmopressin with potentiated anti-diuretic activity. Pharma. Res. 16 (1999) 1674-1679
    • (1999) Pharma. Res. , vol.16 , pp. 1674-1679
    • Wang, J.1    Shen, D.2    Shen, W.-C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.